Parameters | OR (95% CI) | p value |
---|---|---|
Patient-related variables | ||
Age | 1.016 (0.974–1.059) | 0.467 |
Sex | ||
Male/Female | 0.5789 (0.1962–1.7081) | 0.325 |
BMI* | 1.0009 (0.8558–1.1706) | 0.991 |
ASA-PS** | ||
1/2 | 2.3333 (0.6916–7.8719) | 0.172 |
1/3 | 2.0000 (0.1662–24.0689) | 0.585 |
2/3 | 0.8571 (0.0816–9.0087) | 0.898 |
Tumor-related variables | ||
Depth of the tumor | ||
< pT2/> pT3 | 0.7846 (0.2575–2.3901) | 0.67 |
Maximum diameter of tumor (mm) | 0.9975 (0.9821–1.0132) | 0.746 |
Site of inferior margin of the tumor | ||
Rectum/Anal canal | 1.5479 (0.4533–5.5003) | 0.473 |
Simultaneous distant metastasis | 0.4444 (0.0500–3.9522) | 0.467 |
Therapeutic variables | ||
Preoperative therapy | ||
Total | 1.6667 (0.5475–5.074) | 0.369 |
NCRT*** | 2.6133 (0.6214–10.9901) | 0.19 |
Systemic chemotherapy | 1.0424 (0.2880–3.774) | 0.95 |
Surgical approach | ||
Endoscopic/Robot | 0.5556 (0.1175–2.6277) | 0.459 |
Endoscopic/Trans-perineal | 1.1667 (0.2166–6.2840) | 0.858 |
Robot/Trans-perineal | 2.100 (0.2507–17.5941) | 0.494 |
Multivisceral resection | 2.344 (0.4735–11.6006) | 0.297 |
Lateral pelvic lymphnode dissection | 0.8357 (0.2934–2.3807) | 0.737 |
Route of stoma | ||
Transperitoneal/Retroperitoneal | 1.286 (0.3987–4.1514) | 0.673 |
Pelvic peritoneal closure | 3.2110 (0.1029–3.6031) | 0.012 |
Operating time | 0.2071 (0.0139–4.8280) | 0.245 |
Bleeding | 1.0002 (0.9983–1.0023) | 0.794 |
Transfusion | 0.6765 (0.1304–3.5095) | 0.642 |
Residual tumor | ||
R0#/R1## | 0.3469 (0.0206–5.857) | 0.463 |
R0#/R2### | 1.3878 (0.1449–13.2948) | 0.776 |
R1##/R2### | 4.0000 (0.1168–136.9573) | 0.442 |
Postoperative systemic chemotherapy | 0.6282 (0.2146–1.8391) | 0.396 |
Postoperative variables | ||
Postoperative complication | ||
Perineal wound dehiscence | 3.3333 (0.7429–149571) | 0.122 |
Pelvic abscess | 0.3194 (0.0372–2.7399) | 0.298 |
Urinary disorder | 0.9375 (0.2253–3.9009) | 0.929 |
Ileus | 0.7899 (0.1492–4.1814) | 0.782 |
Length of postoperative hospital stay | 1.0025 (0.9650–10415) | 0.897 |